The new plant will give Novartis end-to-end capabilities centered on North Carolina, where it plans to have five facilities ...
Novartis has finalized its $23 billion U.S. manufacturing and R&D expansion with plans for a new active pharmaceutical ingredient facility in Morrisville, North Carolina. The 56,200-square-foot site ...
Novartis will construct an active pharmaceutical ingredient (API) facility in Morrisville, North Carolina, the company said ...
CDMO company Cambrex completed the second phase of an expansion at its Snapdragon Chemistry API production facility in Waltham, Massachusetts. The project added 51,000 square feet to the facility’s ...
The global contract development and manufacturing organization announced March 23 it completed initial engineering studies for an expanded facility in Charles City, Iowa. Groundbreaking for the new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results